> To find out what happens when people stop taking GLP-1s, Al-Aly’s team of researchers tracked the health of more than 333,000 United States veterans with type 2 diabetes for three years.
The same thing happened when the same researcher did studies on Covid using similar datasets. There’s likely some generalizability but part of the reason the absolute risk is so high is because VA patients are a group already at high risk. It’s partly a failure of science journalism this caveat gets missed but seems like it is also one Al-Aly is happy to allow.